#Gliflozins, Typ-2-#Diabetes, #Herzinsuffizienz #Nierenfunktion
RT @NEJM@twitter.com
New review by Eugene Braunwald, M.D., reviews the actions of SGLT2 inhibitors and their implications in the management of cardiovascular disease. https://nej.md/3MLuORp
#Gliflozins #diabetes #herzinsuffizienz #Nierenfunktion